Summary
The persisting high prevalence of allergic diseases in industrialised countries and limited causal therapeutic approaches demand evidence-based measures of primary prevention. The recommendations as published in the guideline of 2009 were updated and consented on the basis of a systematic literature search.
Evidence was searched for the period May 2008 -May 2013 in the electronic databases
Cochrane and MEDLINE as well as in reference lists of recent reviews and by contacting experts. The retrieved citations were screened for relevance first by title and abstract in a second step as full paper. Levels of evidence were assigned to each included study and the methodological quality of the studies was assessed as high or low. Finally the revised recommendations were formally consented (nominal group process) by representatives of relevant societies and organisations including a self-help group.
Of originally 3284 hits, 165 studies (15 systematic reviews, 1 meta analysis, 31 RCTs, 65 cohort-, 12 case-control, and 41 cross sectional studies) were included and critically appraised.
Grossly unchanged remained the recommendations on full breast feeding over 4 months for allergy prevention (alternatively hypoallergenic formulas for risk babies), avoidance of overweight, fish consumption (during pregnancy / breast feeding and as solid food in the first year), reduction of the exposure to indoor and outdoor air pollutants, avoidance of environmental tobacco smoke, avoidance of a mould-promoting indoor climate, and on vaccination according to current recommendations. The statement that a reduction of the house dust mite allergen load is not recommended as a measure of primary prevention also remained unchanged. Families with risk babies should not aquire a cat. Dogs in a household are not associated with an increased allergy risk. The recommendation, that the increased asthma risk in children born via Caesarean section should be considered, was newly introduced to this guideline. Further statements regarding pre and probiotics, psychosocial factors, drugs, and various food components were adopted.
The revision of this guideline on a profound evidence basis led to a conformation of existing recommendations, substantial revisions, and new recommendations. This update should provide evidence-based and current recommendations for the primary prevention of allergies.
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Einleitung
Allergische Erkrankungen, wie allergisches Asthma, Heuschnupfen und das atopische Ekzem verblieben in den westlichen Industrienationen auch in den letzten Jahren auf einem hohen Prävalenzniveau (Asher 2006) . Die Ursachen für die Entwicklung und Zunahme sind nach wie vor weitgehend ungeklärt. Da die kausalen Therapieansätze beschränkt sind, kommt der Prävention besondere Bedeutung zu, wenn man dem ansteigenden Trend begegnen will . Mit Unterstützung des Bundesministeriums für Gesundheit und soziale Sicherung wurde im Rahmen des Aktionsbündnisses Allergieprävention (abap) im Jahr 2004 die erste S3-Leitlinie zur Allergieprävention veröffentlicht und 5 Jahre später erstmals überarbeitet (Muche-Borowski 2009) . Diese wurde nun zum zweiten Mal, der Methodik für evidenzbasierte und konsentierte Leitlinien folgend, überarbeitet. Die aktuelle Leitlinienversion und die zugrunde liegende Methodik werden im Folgenden dargestellt.
Methodik
Auch die Methodik der Überarbeitung dieser Leitlinie folgte nationalen und internationalen
Standards zur Entwicklung evidenzbasierter und konsentierter Leitlinien (Muche-Borowski 2012) (Grimshaw 1995) (Sacket 1997 Zusätzlich bestehen gesundheitliche Bedenken (Agostoni C et al. 2006 , Westmark CJ 2014 , die in jüngster Zeit diskutiert wurden (Vandenplas 2014 ). An der Empfehlung, dass sich soja- (Schoenbaum 1990 (Black 1999 (Lorenz 1999 (Lorenz 1999) 
